...
【24h】

Intraindividual comparison of contrast media concentrations for combined abdominal and thoracic MDCT.

机译:腹部和胸部联合MDCT造影剂浓度的个体内比较。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The purpose of this study was an intraindividual comparison of the degrees of MDCT contrast enhancement achieved with agents containing 300 and 370 mg I/mL. SUBJECTS AND METHODS: Seventy-five patients underwent baseline and follow-up MDCT of the chest and abdomen with contrast media containing a high concentration of iodine (iopromide 370 mg I/mL) and standard iodine concentration (iopromide 300 mg I/mL). The total iodine load (37 g) and the iodine delivery rate (1.29 g/s) were identical for the two protocols. Contrast enhancement in the chest (right and left ventricles, pulmonary trunk, descending aorta) and the abdomen (aorta, inferior vena cava, portal vein, and liver) was determined. Results were compared by use of paired Student's t tests, and p was adjusted with Bonferroni correction for multiple comparisons (p 0.0056). CONCLUSION: Given equivalent iodine load and delivery rate, the use of 300 mg I/mL contrast medium results in better contrast enhancement than use of 370 mg I/mL contrast medium in CT of the chest. For the portal venous phase of CT of the abdomen, there was no significant difference in contrast enhancement for the two concentrations of iodine.
机译:目的:本研究的目的是对含300和370 mg I / mL药物的MDCT造影剂增强程度进行个体化比较。研究对象和方法:75例患者接受了基线和胸部和腹部的MDCT随访,并接受了造影剂,造影剂中含有高浓度的碘(碘化丙啶370 mg I / mL)和标准碘浓度(碘化丙啶300 mg I / mL)。两种方案的总碘负荷(37 g)和碘释放速率(1.29 g / s)相同。确定了胸部(左右心室,肺干,降主动脉)和腹部(主动脉,下腔静脉,门静脉和肝脏)的对比度增强。使用成对的Student t检验比较结果,并使用Bonferroni校正对p进行多次比较以进行调整(p <或= 0.0056)。结果:除了左心室(右心室,359 +/- 100 H vs 320 +/- 102)以外,在胸部所有解剖部位,300 mg I / mL方案的对比度增强明显高于370 mg I / mL方案。 H,p = 0.003;肺干,334 +/- 96 H vs 303 +/- 89 H,p = 0.003;左心室,310 +/- 54 H vs 300 +/- 51 H,p = 0.036;降主动脉,300 +/- 63 H与277 +/- 57 H,p = 0.0002)。在腹部没有发现统计学上的显着差异(所有p> 0.0056)。结论:在碘负荷和分娩率相等的情况下,与在胸部CT中使用370 mg I / mL造影剂相比,使用300 mg I / mL造影剂可产生更好的造影剂增强效果。对于腹部CT的门静脉期,两种浓度的碘在造影剂增强方面没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号